Annexin V and caspase-3 apoptosis assays

SV Smruthi Vijayaraghavan
CK Cansu Karakas
ID Iman Doostan
XC Xian Chen
TB Tuyen Bui
MY Min Yi
AR Akshara S. Raghavendra
YZ Yang Zhao
SB Sami I. Bashour
NI Nuhad K. Ibrahim
MK Meghan Karuturi
JW Jing Wang
JW Jeffrey D. Winkler
RA Ravi K. Amaravadi
KH Kelly K. Hunt
DT Debu Tripathy
KK Khandan Keyomarsi
request Request a Protocol
ask Ask a question
Favorite

Apoptotic cells were measured by using the Alexa Fluor 488 Annexin V Dead Cell Apoptosis kit (Invitrogen, Waltham, MA) according to the manufacturer’s protocol. Briefly, cells were plated (1 × 105 cells per plate) on 10-cm plates and treated with the indicated agents for 6 days and allowed to recover for 4 days. Cells were collected at the end of treatment (6 days) or after treatment+recovery, washed with 1 × Annexin binding buffer and stained with a solution of Alexa Fluor 488 Annexin V and propidium iodide (100 μg ml−1) as directed by the protocol. Samples were then analysed on the Beckman Coulter Gallios Flow Cytometer, and data were analysed with Kaluza software to obtained the percentages of Annexin V-positive/propidium iodide-negative (early apoptosis) and Annexin V-positive/propidium iodide-positive (late apoptosis) cells.

For the caspase-3 activity assay, following drug treatment, cells were collected, washed with a solution of PBS with 2% FBS and fixed with 100 μl of the fixation solution from the Cytofix/CytoPerm kit (BD Biosciences). Cells were then washed with Perm/Wash buffer and stained with phycoerythrin-conjugated rabbit active caspase-3 antibody (BD Biosciences) for 30 min on ice. Cells were finally washed, resuspended in the PBS with 2% FBS solution and analysed on the Becton Dickinson FACS Calibur Flow Cytometer to obtain the percentage of caspase-3-positive cells.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A